Public Employees Retirement System of Ohio Acquires 5,569 Shares of HealthEquity, Inc. (NASDAQ:HQY)

Public Employees Retirement System of Ohio lifted its stake in shares of HealthEquity, Inc. (NASDAQ:HQY - Free Report) by 6.1% in the fourth quarter, according to the company in its most recent filing with the SEC. The fund owned 97,323 shares of the company's stock after buying an additional 5,569 shares during the quarter. Public Employees Retirement System of Ohio owned about 0.11% of HealthEquity worth $9,338,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds have also bought and sold shares of the stock. Pier Capital LLC acquired a new stake in shares of HealthEquity during the fourth quarter worth $8,024,000. HighTower Advisors LLC raised its stake in HealthEquity by 4.8% in the 4th quarter. HighTower Advisors LLC now owns 95,075 shares of the company's stock worth $9,122,000 after purchasing an additional 4,370 shares in the last quarter. Wells Fargo & Company MN raised its stake in HealthEquity by 4.7% in the 4th quarter. Wells Fargo & Company MN now owns 124,940 shares of the company's stock worth $11,988,000 after purchasing an additional 5,594 shares in the last quarter. Geneva Capital Management LLC boosted its holdings in HealthEquity by 24.6% in the 4th quarter. Geneva Capital Management LLC now owns 1,048,903 shares of the company's stock valued at $100,642,000 after purchasing an additional 206,894 shares during the period. Finally, Charles Schwab Investment Management Inc. grew its position in shares of HealthEquity by 2.4% during the 4th quarter. Charles Schwab Investment Management Inc. now owns 1,086,811 shares of the company's stock worth $104,280,000 after purchasing an additional 25,004 shares in the last quarter. Institutional investors and hedge funds own 99.55% of the company's stock.

Wall Street Analysts Forecast Growth

A number of equities research analysts have recently weighed in on HQY shares. KeyCorp dropped their price target on shares of HealthEquity from $110.00 to $100.00 and set an "overweight" rating for the company in a research report on Wednesday, April 16th. Raymond James upgraded HealthEquity from an "outperform" rating to a "strong-buy" rating and lowered their price objective for the stock from $120.00 to $115.00 in a research note on Tuesday, March 25th. Royal Bank of Canada began coverage on HealthEquity in a research report on Thursday, May 22nd. They set an "outperform" rating and a $112.00 target price for the company. The Goldman Sachs Group reduced their target price on HealthEquity from $107.00 to $94.00 and set a "neutral" rating on the stock in a report on Thursday, March 27th. Finally, Barrington Research restated an "outperform" rating and issued a $112.00 price target on shares of HealthEquity in a research report on Friday, April 11th. One equities research analyst has rated the stock with a hold rating, ten have given a buy rating and one has issued a strong buy rating to the stock. Based on data from MarketBeat.com, HealthEquity has an average rating of "Buy" and an average price target of $112.33.

HealthEquity Price Performance

Shares of HQY stock traded up $0.13 on Friday, hitting $101.11. 960,737 shares of the company's stock were exchanged, compared to its average volume of 809,286. The company has a 50 day moving average of $89.41 and a 200 day moving average of $97.48. The stock has a market cap of $8.75 billion, a P/E ratio of 92.76, a price-to-earnings-growth ratio of 1.60 and a beta of 0.45. The company has a debt-to-equity ratio of 0.51, a current ratio of 3.20 and a quick ratio of 3.20. HealthEquity, Inc. has a 12 month low of $65.01 and a 12 month high of $115.59.

Insider Buying and Selling at HealthEquity

In other news, EVP Michael Henry Fiore sold 8,881 shares of the stock in a transaction on Friday, April 4th. The stock was sold at an average price of $78.26, for a total value of $695,027.06. Following the completion of the transaction, the executive vice president now directly owns 56,655 shares in the company, valued at approximately $4,433,820.30. This represents a 13.55% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, Director Robert W. Selander sold 5,750 shares of the business's stock in a transaction on Wednesday, April 9th. The stock was sold at an average price of $77.65, for a total value of $446,487.50. Following the sale, the director now owns 84,969 shares in the company, valued at $6,597,842.85. This represents a 6.34% decrease in their position. The disclosure for this sale can be found here. Company insiders own 1.50% of the company's stock.

HealthEquity Company Profile

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.